Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2021)

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Barrett JR. et al, (2021), Nature Medicine, 27, 279 - 288

MAIT cell activation augments adenovirus vector vaccine immunogenicity

Provine NM. et al, (2021), Science, 371, 521 - 526

Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule

Rollier CS. et al, (2020), Scientific Reports, 10

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

Ainsworth M. et al, (2020), The Lancet Infectious Diseases, 20, 1390 - 1400

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine

O’Connor D. et al, (2020), Molecular Systems Biology, 16

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478

The effect of a single 4CMenB vaccine booster in young people more than ten years after infant immunisation: protocol of an exploratory immunogenicity study

Davis K. et al, (2019), Trials, 20

Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane-bound endotoxin of its outer membrane vesicle component.

Sheerin D. et al, (2019), Scientific reports, 9

Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria.

Milicic A. et al, (2019), Scientific reports, 9

Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis.

Awanye AM. et al, (2019), Scientific reports, 9

Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination

Flaxman A. et al, (2019), Vaccine, 37, 494 - 501

Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease

Elshina E. et al, (2019), Vaccine, 37, 502 - 509

Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region

Kim YC. et al, (2018), Virology Journal, 15

Rapid travel to a Zika vaccine: are we heading towards success or more questions?

Britto C. et al, (2018), Expert Opinion on Biological Therapy, 18, 1171 - 1179

Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007

Norheim G. et al, (2018), Vaccine, 36, 1297 - 1303

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

Milicic A. et al, (2017), Scientific Reports, 7

Development of persistent gastrointestinal S. aureus carriage in mice

Flaxman A. et al, (2017), Scientific Reports, 7

The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens

Diemen PMV. et al, (2017), Scientific Reports, 7

Load More

Include forthcoming?